These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
||
|
|
|
Check the appropriate box:
|
||
o
|
Preliminary Proxy Statement
|
|
o
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)
|
|
þ
|
Definitive Proxy Statement
|
|
o
|
Definitive Additional Materials
|
|
o
|
Soliciting Material Pursuant to Rule 14a-12
|
Payment of Filing Fee (Check the appropriate box):
|
|||||
þ
|
|
No fee required.
|
|||
|
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|||
|
|
(1
|
)
|
|
Title of each class of securities to which transaction applies:
|
|
|
(2
|
)
|
|
Aggregate number of securities to which transaction applies:
|
|
|
(3
|
)
|
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
(4
|
)
|
|
Proposed maximum aggregate value of transaction:
|
|
|
(5
|
)
|
|
Total fee paid:
|
o
|
|
Fee paid previously with preliminary materials.
|
|||
o
|
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|||
|
|
(1
|
)
|
|
Amount Previously Paid:
|
|
|
(2
|
)
|
|
Form, Schedule or Registration Statement No.:
|
|
|
(3
|
)
|
|
Filing Party:
|
|
|
(4
|
)
|
|
Date Filed:
|
|
Sincerely,
|
|
![]() |
|
James J. Kim
|
|
Executive Chairman of the Board
|
|
|
|
|
|
1.
|
Election of the ten directors named in the proxy statement;
|
2.
|
An advisory vote to approve the compensation of our named executive officers;
|
3.
|
Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2019; and
|
4.
|
Such other business as may properly come before the meeting and any adjournment or postponement.
|
|
BY ORDER OF THE BOARD OF DIRECTORS
|
|
![]() |
|
Gil C. Tily
|
|
Executive Vice President, Chief
|
|
Administrative Officer, General Counsel and
|
|
Corporate Secretary
|
|
|
|
YOUR VOTE IS IMPORTANT
|
||
|
||
To assure your representation at the Annual Meeting, you are requested to complete, sign and date the enclosed proxy as promptly as possible and return it in the enclosed postage-prepaid envelope, or submit your proxy by internet or telephone.
|
||
|
|
|
|
Important Notice Regarding the Availability of Proxy Materials for the Stockholders Meeting to Be Held on May 15, 2019:
|
|
|
|
|
The Proxy Statement for the Annual Meeting of Stockholders and our Annual Report to Stockholders for the year ended December 31, 2018 are available at:
www.edocumentview.com/amkr.
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
Q:
|
What may I vote on?
|
|
A:
|
1. The election of ten nominees named in this proxy statement to serve on our Board of Directors;
|
|
|
2. An advisory vote to approve the compensation of our named executive officers;
|
|
|
3. The ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting
|
|
|
firm for the year ending December 31, 2019.
|
|
|
|
|
Q:
|
How does the Board recommend I vote on the proposals?
|
|
A:
|
The Board recommends a vote FOR each of the director nominees, FOR the approval, on an advisory basis, of the compensation of our named executive officers, and FOR the ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2019.
|
|
|
|
|
Q:
|
Who is entitled to vote?
|
|
A:
|
Stockholders of record as of the close of business on March 20, 2019 (the “Record Date”) are entitled to vote at the Annual Meeting. Each stockholder is entitled to one vote for each share of common stock held on the Record Date. As of the Record Date, 239,592,109 shares of Amkor’s common stock were outstanding.
|
|
|
|
|
Q:
|
How do I vote?
|
|
A:
|
Registered holders may vote:
|
|
|
l
|
In person at the Annual Meeting;
|
|
l
|
By mail by signing and dating each proxy card you receive and returning it in the postage-prepaid envelope; or
|
|
l
|
By internet or telephone, by following the instructions on the proxy card.
|
|
|
|
|
If your shares are held by a bank, brokerage firm or other record holder, please refer to your proxy card or other information provided to you for instructions on how to vote.
If you hold your shares through a broker and do not provide your broker with specific voting instructions, under the rules that govern brokers in such circumstances, your broker will have the discretion to vote such shares on routine matters, but not on non-routine matters. Even though we are a Nasdaq-listed company, the New York Stock Exchange (“NYSE”) rules govern how a broker licensed by the NYSE can vote shares it holds on behalf of stockholders of Nasdaq-listed companies. As a result:
|
|
|
l
|
Your broker will not have the authority to exercise discretion to vote your shares with respect to the election of directors, the advisory vote to approve the compensation of our named executive officers because NYSE rules treat those matters as non-routine.
|
|
l
|
Your broker will have the authority to exercise discretion to vote your shares with respect to the ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2019 because that matter is treated as routine under NYSE rules.
|
|
Because the proposals to be acted upon at the Annual Meeting include both routine and non-routine matters, we anticipate that brokers may return proxy cards that vote uninstructed shares “FOR” or “AGAINST” the ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2019, but expressly state that the broker is NOT voting on the election of directors or the advisory vote to approve the compensation of our named executive officers. A broker’s withholding of a vote, in this case with respect to the election of directors and the advisory vote with respect to the compensation of our named executive officers, is referred to as a “broker non-vote”. Broker non-votes will not be counted as present or represented for purposes of determining whether stockholder approval of a matter has been obtained and thus will not have an effect on the outcome of the vote.
If you abstain from voting on the approval (on an advisory basis) of the compensation of our named executive officers (Proposal Two), the abstention will have the same effect as a vote against the proposal. If you abstain from voting on the election of directors (Proposal One), or on the ratification of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2019 (Proposal Three), the abstention will not have an effect on the outcome of the vote.
|
|
|
|
|
Q.
|
What is the voting requirement to approve each of the proposals?
|
|
A.
|
In the election of directors (Proposal One), the ten directors receiving the highest number of affirmative votes cast will be elected. Approval, on an advisory basis, of the compensation of our named executive officers (Proposal Two), and ratification of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2019 (Proposal Three), requires the affirmative vote of a majority of the shares present in person or represented by proxy and entitled to vote on that proposal at the annual meeting. Abstentions are not counted in the tally of votes FOR or AGAINST a proposal. A withheld vote is the same as an abstention.
|
|
|
|
|
Q:
|
What is a “quorum”?
|
|
A:
|
A “quorum” is a majority of the outstanding shares entitled to vote at the meeting being present at the meeting or represented by proxy. There must be a quorum for the meeting to be held and action to be validly taken. If you submit a properly executed proxy, even if you abstain from voting, then your shares will be counted toward the presence of a quorum. If a broker indicates on a proxy that it does not have discretionary authority to vote certain shares on a particular matter (broker non-votes), those shares will not be counted as present or represented for purposes of determining whether stockholder approval of that matter has been obtained but will be counted for purposes of establishing a quorum.
|
|
|
|
|
Q:
|
How can I change my vote or revoke my proxy?
|
|
A:
|
If you are a registered holder, you have the right to revoke your proxy and change your vote at any time before the meeting by (i) submitting a later-dated proxy by mail, internet or telephone; (ii) mailing a written notice of revocation to the attention of Amkor’s Corporate Secretary, Amkor Technology, Inc., 2045 East Innovation Circle, Tempe, Arizona 85284; or (iii) attending and voting in person at the Annual Meeting. Attendance at the Annual Meeting, in and of itself, will not constitute a revocation of a proxy. If your shares are held by a bank, brokerage firm or other record holder, please contact that firm or holder for instructions on how to change your vote or revoke your proxy.
|
|
|
|
|
Q:
|
What does it mean if I get more than one proxy card?
|
|
A:
|
It means you hold shares registered in more than one account. Submit all proxies to ensure that all your shares are voted.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Q:
|
Who can attend the Annual Meeting?
|
|
A:
|
All stockholders as of the Record Date may attend. For stockholders of record, government-issued picture identification will be required to enter the meeting. If your shares are held in street name, please bring proof of share ownership with you to the Annual Meeting as well as your government-issued picture identification. A copy of your brokerage account statement or an omnibus proxy (which you can get from your broker) will serve as proof of share ownership. Individuals arriving at the meeting site will not be admitted unless we can verify ownership as of the Record Date as described above or by some other means. Attendees will be subject to security inspections and will be required to comply with other security and procedural measures in place at the Annual Meeting. Representatives of the company will be at the entrance to the Annual Meeting, and these representatives will be authorized on the company's behalf to determine whether the admission policies and procedures are being followed and whether you will be granted admission to the Annual Meeting.
|
|
|
|
|
Q:
|
How will voting on any other business be conducted?
|
|
A:
|
Although we do not know of any business to be considered at the Annual Meeting other than the proposals described in this proxy statement, if any other business is properly presented at the Annual Meeting, your proxy gives authority to James J. Kim, Amkor’s Executive Chairman, and Stephen D. Kelley, Amkor’s President and Chief Executive Officer, to vote your shares on such matters at their discretion.
|
Q:
|
How and when may I submit proposals for the 2020 Annual Meeting?
|
|
A:
|
To have your proposal included in our proxy statement and form of proxy for the 2020 Annual Meeting of Stockholders, we must receive your written proposal no later than December 14, 2019. You may submit proposals after this date for consideration at the 2020 Annual Meeting of Stockholders, but we are not required to include any proposal submitted after this date in the proxy statement or proxy card.
If you intend to submit a proposal or nomination for director for the 2020 Annual Meeting (but not seek inclusion of such proposal or nomination in the company’s proxy materials), you must comply with the advance notice provisions in our bylaws. To be timely, we must receive written notice of your proposal no earlier than January 16, 2020 and no later than February 15, 2020.
All proposals must, under law, be an appropriate subject for stockholder action and must be submitted in writing to Amkor’s Corporate Secretary, Amkor Technology, Inc., 2045 East Innovation Circle, Tempe, Arizona 85284. You should also be aware of certain other requirements you must meet to have your proposal brought before the 2019 Annual Meeting. These requirements are explained in Rule 14a-8 of the Securities Exchange Act of 1934 (the "Exchange Act"), as amended, and in our bylaws.
|
|
|
|
|
Q:
|
Who is soliciting proxies?
|
|
A:
|
This solicitation of proxies is made by the Board of Directors. All related costs will be borne by Amkor.
We have retained the services of Georgeson Inc. to aid in the distribution of our Annual Meeting materials to brokers, bank nominees and other institutional owners. We estimate we will pay Georgeson Inc. a fee of approximately $1,500 for such services.
Proxies may also be solicited by certain of Amkor’s officers and regular employees, without additional compensation, in person or by telephone or facsimile.
|
Name
|
|
Age
|
|
Position
|
James J. Kim
|
|
83
|
|
Executive Chairman of the Board
|
John T. Kim
|
|
49
|
|
Executive Vice Chairman of the Board
|
Stephen D. Kelley
|
|
56
|
|
President, Chief Executive Officer and Director
|
Douglas A. Alexander(3)(4)
|
|
57
|
|
Director
|
Roger A. Carolin(1)(2)(3)(4)
|
|
63
|
|
Director
|
Winston J. Churchill(2)(3)(4)
|
|
78
|
|
Lead Independent Director
|
Susan Y. Kim
|
|
56
|
|
Director
|
MaryFrances McCourt(1)(4)
|
|
57
|
|
Director
|
Robert R. Morse(1)(2)(4)
|
|
63
|
|
Director
|
David N. Watson(2)(4)
|
|
60
|
|
Director
|
(1)
|
Member of Audit Committee.
|
(2)
|
Member of Compensation Committee.
|
(3)
|
Member of Nominating and Governance Committee.
|
(4)
|
Qualifies as “independent” under the definition set forth in the Nasdaq listing standards and U.S. Securities and Exchange Commission (“SEC”) regulations, as determined by the Board of Directors.
|
•
|
pre-approving all audit, audit-related and non-audit services provided to Amkor by Amkor’s independent registered public accounting firm;
|
•
|
appointing, compensating, retaining and overseeing the work of the independent registered public accounting firm;
|
•
|
reviewing and providing guidance with respect to the external audit and Amkor’s relationship with its independent registered public accounting firm;
|
•
|
reviewing and discussing with management and the independent registered public accounting firm the contents of periodic reports filed with the SEC and Amkor’s earnings releases;
|
•
|
reviewing and approving related party transactions (unless such review and approval is conducted by another independent body of the Board of Directors);
|
•
|
reviewing and providing guidance regarding Amkor’s internal audit function;
|
•
|
discussing with management and internal audit representatives the activities, organizational structure and qualifications of our internal audit function;
|
•
|
reviewing any significant findings presented by management or internal auditors regarding the effectiveness of, or any deficiencies in, the design or operation of internal control over financial reporting and any fraud, whether or not material, that involves management or other employees who have a significant role in our internal control over financial reporting, and reviewing before release the disclosure regarding Amkor’s system of internal control over financial reporting required under SEC rules to be contained in Amkor’s periodic filings and the attestations or reports by the independent auditors relating to such disclosure;
|
•
|
overseeing compliance with the requirements of the SEC for disclosure of the services provided by our independent registered public accounting firm and Audit Committee members, member qualifications and activities;
|
•
|
reviewing any legal matters that our general counsel has concluded could have a significant impact on our financial statements;
|
•
|
reviewing our policies and practices with respect to financial risk assessment and financial risk management;
|
•
|
instituting special investigations as and when the Audit Committee determines appropriate and necessary;
|
•
|
annually reviewing its own charter, structure, processes and membership requirements; and
|
•
|
establishing procedures for the confidential, anonymous submission by employees of concerns about questionable accounting or auditing matters.
|
•
|
annually reviewing and approving the compensation, including annual base salaries and annual incentive opportunities and compensation policies for our executive officers;
|
•
|
reviewing and making recommendations to the Board regarding director compensation;
|
•
|
reviewing, approving and/or making recommendations to the Board regarding all forms of compensation to be provided to the Chief Executive Officer and all of our other executive officers, and reviewing, approving and/or making recommendations to the Board regarding general compensation goals, guidelines and bonus criteria for our employees;
|
•
|
administering and interpreting the terms and conditions of all current and future equity incentive plans;
|
•
|
reviewing, approving and/or making recommendations to the Board, as appropriate, regarding other plans that provide for compensation to our employees and directors;
|
•
|
reviewing and approving any material amendments to our 401(k) plan;
|
•
|
assessing and monitoring risks related to the company's compensation policies and practices,
|
•
|
reviewing and approving the compensation discussion and analysis and committee report for inclusion in our annual proxy statement;
|
•
|
authorizing the repurchase of shares from terminated employees; and
|
•
|
annually reviewing the adequacy of its charter.
|
•
|
evaluating the current composition, organization and governance of the Board and its Committees and making recommendations regarding such matters to the Board;
|
•
|
periodically assessing desired Board qualifications, expertise and characteristics for potential Board members, and evaluating and proposing nominees for election to the Board;
|
•
|
developing policies and procedures regarding the review and recommendation of nominees for director;
|
•
|
overseeing the Board of Directors’ performance evaluation process;
|
•
|
evaluating and making recommendations to the Board of Directors concerning the appointment of directors to Board committees, the selection of committee chairs and the proposal of a slate of nominees for election to the Board of Directors;
|
•
|
evaluating and recommending termination of individual directors in accordance with the Board’s governance principles;
|
•
|
periodically reviewing and re-examining the Nominating and Governance Committee’s charter, structure processes and membership and making recommendations to the Board of Directors;
|
•
|
developing and recommending Corporate Governance Guidelines for the Board of Directors, and periodically reviewing these guidelines as well as our corporate governance practices and procedures;
|
•
|
periodically reviewing our Code of Business Conduct; and
|
•
|
periodically reviewing continuing education for members of the Board.
|
•
|
whether the transaction is in the best interest of the company and its stockholders;
|
•
|
the nature of the related party’s interest in the transaction;
|
•
|
the material terms of the transaction, including, without limitation, the amount and type of transaction;
|
•
|
the importance of the transaction to the related party;
|
•
|
whether the transaction would impair the judgment of a director or executive officer to act in our best interest; and
|
•
|
any other matters the Audit Committee deems appropriate.
|
Annual Retainer for Board Members
|
|
$50,000
|
|
|
Additional Annual Fees:
|
|
|||
Lead Independent Director
|
25,000
|
|
|
|
Audit Committee Chairman
|
15,000
|
|
|
|
Compensation Committee Chairman
|
15,000
|
|
|
|
Nominating and Governance Committee Chairman
|
10,000
|
|
|
|
Fee per Board and Committee Meeting attended in person
|
2,000
|
|
|
|
Fee per Board and Committee Meeting attended telephonically
|
1,000
|
|
|
Name
|
|
Fees
Earned
or Paid
in Cash ($)
|
|
Stock Awards
($)(3)(6)
|
|
Option
Awards
($)(4)(5)(6)
|
|
Non-Equity
Incentive
Plan
Compensation
($)
|
|
All Other Compensation ($)(7)(8)
|
|
Total ($)
|
|
James J. Kim, Executive Chairman (1)
|
|
700,000
|
|
—
|
|
—
|
|
749,385
|
|
56,436
|
|
1,505,821
|
|
John T. Kim, Executive Vice Chairman (2)
|
|
425,000
|
|
—
|
|
—
|
|
252,769
|
|
10,000
|
|
687,769
|
|
Douglas A. Alexander
|
|
83,000
|
|
49,308
|
|
105,293
|
|
—
|
|
—
|
|
237,601
|
|
Roger A. Carolin
|
|
108,000
|
|
40,000
|
|
83,692
|
|
—
|
|
—
|
|
231,692
|
|
Winston J. Churchill, Lead Independent Director
|
|
143,000
|
|
40,000
|
|
83,692
|
|
—
|
|
—
|
|
266,692
|
|
Susan Y. Kim
|
|
60,000
|
|
40,000
|
|
83,692
|
|
—
|
|
—
|
|
183,692
|
|
MaryFrances McCourt
|
|
80,000
|
|
49,308
|
|
105,293
|
|
—
|
|
—
|
|
234,601
|
|
Robert R. Morse
|
|
92,000
|
|
40,000
|
|
83,692
|
|
—
|
|
—
|
|
215,692
|
|
David N. Watson
|
|
85,000
|
|
40,000
|
|
83,692
|
|
—
|
|
—
|
|
208,692
|
|
(1)
|
Mr. James J. Kim is compensated for his employment as our Executive Chairman of the Board and his compensation is approved annually by the Compensation Committee. Mr. Kim’s 2018 non-equity incentive compensation opportunity was based on the same performance criteria approved by the Compensation Committee for our executive officers, as described below in the Compensation Discussion and Analysis. Mr. Kim also receives health and welfare benefits generally available to our employees.
|
(2)
|
Mr. John T. Kim is compensated for his employment as our Executive Vice Chairman of the Board and his compensation is approved annually by the Compensation Committee. Mr. Kim's 2018 non-equity incentive compensation opportunity was based on the same performance criteria approved by the Compensation Committee for our executive officers, as described below in the Compensation Discussion and Analysis. Mr. Kim also receives health and welfare benefits generally available to our employees.
|
(3)
|
The amounts in the Stock Awards column reflect the aggregate grant date fair value of restricted stock awards granted during the year ended December 31, 2018, calculated in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718, Compensation-Stock Compensation (“FASB ASC 718”). Assumptions used in the calculation of these amounts are included in Note 4 to our Consolidated Financial Statements included in our Annual Report on Form 10-K filed with the SEC on February 22, 2019. For a description of the vesting schedule relating to the restricted stock, see "Equity Compensation" above. Pursuant to SEC rules, the amounts shown exclude the impact of estimated forfeitures related to service-based vesting conditions.
|
(4)
|
The amounts in the Option Awards column reflect the aggregate grant date fair value of such awards granted during the year ended December 31, 2018, calculated in accordance with FASB ASC 718. Assumptions used in the calculation of these amounts are included in Note 4 to our Consolidated Financial Statements included in our Annual Report on Form 10-K filed with the SEC on February 22, 2019. Pursuant to SEC rules, the amounts shown exclude the impact of estimated forfeitures related to service-based vesting conditions.
|
(5)
|
Under the director compensation program, non-employee directors received an annual grant of 20,000 stock options upon re-election. For 2018, stock options were granted on May 1, 2018 with an exercise price of $8.51, the closing price of our common stock on the date of grant. The options will become fully exercisable on May 1, 2019. Mr. Alexander and Ms. McCourt were granted 4,657 stock options upon their election to the Board in February 2018, with an exercise price of $9.45, the closing price of our common stock on the date of grant, and subject to the same terms and conditions that apply to the options granted to non-employee directors. For a description of the vesting schedule relating to the stock options, see "Equity Compensation" above.
|
(6)
|
Total stock options outstanding as of December 31, 2018 for Amkor’s directors (other than Mr. Kelley) are as follows: Mr. James J. Kim — 200,000; Mr. John T. Kim — 295,000; Mr. Alexander — 24,657 Mr. Carolin — 200,000; Mr. Churchill — 60,000; Ms. Susan Y. Kim — 85,000; Ms. McCourt — 24,657; Mr. Morse — 120,000; and Mr. Watson — 100,000. Total stock awards held by Amkor's directors (other than James J. Kim, John T. Kim and Mr. Kelley) as of December 31, 2018 are as follows: Mr. Alexander — 5,685; Mr. Carolin — 22,176; Mr. Churchill — 22,176; Ms. Susan Y. Kim — 22,176; Ms. McCourt — 5,685; Mr. Morse —22,176; and Mr. Watson — 22,176.
|
(7)
|
Reimbursement by the company for certain personal travel expenses by Mr. Kim and his family in accordance with company policy, as approved by the Compensation Committee. This reimbursement is calculated based on actual expenses incurred.
|
(8)
|
Company matching contributions to Mr. Kim's 401(k) account.
|
Name
|
|
Age
|
|
Position
|
Stephen D. Kelley
|
|
56
|
|
President and Chief Executive Officer
|
Megan Faust
|
|
45
|
|
Corporate Vice President and Chief Financial Officer
|
YoungKuk Park
|
|
60
|
|
Executive Vice President of Worldwide Manufacturing Operations, and
President of Amkor Technology Korea
|
Giel Rutten
|
|
61
|
|
Executive Vice President, Advanced Products
|
John C. Stone
|
|
62
|
|
Executive Vice President, Worldwide Sales and Marketing
|
Gil C. Tily
|
|
65
|
|
Executive Vice President, Chief Administrative Officer, General Counsel and Corporate Secretary
|
|
Target Bonus as a
Percentage of
Base Pay
|
James J. Kim
|
135%
|
Executive Chairman (1)
|
|
John T. Kim
|
75
|
Executive Vice Chairman (1)
|
|
Stephen D. Kelley
|
135
|
President and Chief Executive Officer
|
|
Megan Faust
|
75
|
Corporate Vice President and Chief Financial Officer
|
|
Gil C. Tily
|
85
|
Executive Vice President, Chief Administrative Officer, General Counsel
|
|
and Corporate Secretary
|
|
John C. Stone
|
75
|
Executive Vice President, Worldwide Sales and Marketing
|
|
Giel Rutten
|
75
|
Executive Vice President, Advanced Products
|
|
(1)
|
While Mr. James J. Kim and Mr. John T. Kim are employees, they are not executive officers. They have been included here because their incentive compensation for 2018 was established based on the same performance criteria approved by the Compensation Committee for our executive officers.
|
•
|
A threshold, target and maximum level of performance was established with respect to (i) Sales, (ii) Operating Income and (iii) China/Taiwan Sales.
|
•
|
0% of the target bonus amount was to be paid if less than the threshold levels of performance were achieved with respect to all three performance goals;
|
•
|
100% of the target bonus amount was to be paid if the target levels of performance were achieved with respect to all three performance goals; and
|
•
|
150% of the target bonus amount was to be paid if the maximum levels of performance were achieved with respect to all three performance goals.
|
Name
|
2018 Target Bonus
|
2018 Actual Bonus
|
2018 Actual Bonus
(as % of Target)
|
James J. Kim
|
$945,000
|
$749,385
|
79.3%
|
John T. Kim
|
318,750
|
252,769
|
79.3%
|
Stephen D. Kelley
|
1,161,003
|
920,675
|
79.3%
|
Megan Faust
|
281,250
|
223,031
|
79.3%
|
Gil C. Tily
|
518,500
|
411,171
|
79.3%
|
John C. Stone
|
412,500
|
327,113
|
79.3%
|
Giel Rutten
|
365,630
|
289,945
|
79.3%
|
Name and Principal Position
|
|
Year
|
|
Salary($)
|
|
Bonus ($)(1)
|
|
Stock Awards ($)(2)
|
|
Option Awards
($)(3)
|
|
Non-Equity
Incentive
Plan
Compensation ($)(4)
|
|
All Other
Compensation($)(5)
|
|
Total($)
|
||
Stephen D. Kelley
|
|
2018
|
|
858,656
|
|
2,125,000
|
|
|
—
|
|
|
—
|
|
920,675
|
|
15,091
|
|
3,919,422
|
President and
|
|
2017
|
|
800,962
|
|
1,793,151
|
|
|
1,972,000
|
|
1,806,750
|
|
1,476,833
|
|
10,000
|
|
7,859,696
|
|
Chief Executive Officer
|
|
2016
|
|
700,000
|
|
—
|
|
|
—
|
|
|
—
|
|
960,400
|
|
12,270
|
|
1,672,670
|
Megan Faust
|
|
2018
|
|
372,692
|
|
75,000
|
|
|
—
|
|
|
—
|
|
223,031
|
|
11,077
|
|
681,800
|
Corporate Vice President and
|
|
2017
|
|
312,866
|
|
—
|
|
|
—
|
|
|
481,800
|
|
313,268
|
|
14,514
|
|
1,122,448
|
Chief Financial Officer
|
|
2016
|
|
274,451
|
|
|
|
|
|
283,267
|
|
193,867
|
|
14,109
|
|
765,694
|
||
Gil C. Tily
|
|
2018
|
|
610,000
|
|
—
|
|
|
—
|
|
|
—
|
|
411,171
|
|
11,071
|
|
1,032,242
|
Executive Vice President,
|
|
2017
|
|
605,731
|
|
—
|
|
|
—
|
|
|
702,625
|
|
687,531
|
|
10,000
|
|
2,005,887
|
Chief Administrative Officer,
|
|
2016
|
|
580,000
|
|
—
|
|
|
—
|
|
|
—
|
|
661,606
|
|
14,692
|
|
1,256,298
|
General Counsel and
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
Corporate Secretary
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
John C. Stone
|
|
2018
|
|
549,039
|
|
—
|
|
|
—
|
|
|
—
|
|
327,113
|
|
12,452
|
|
888,604
|
Executive Vice President,
|
|
2017
|
|
521,442
|
|
—
|
|
|
—
|
|
|
602,250
|
|
522,113
|
|
16,374
|
|
1,662,179
|
Worldwide Sales and Marketing
|
|
2016
|
|
500,000
|
|
—
|
|
|
—
|
|
|
—
|
|
503,250
|
|
10,000
|
|
1,013,250
|
Giel Rutten
|
|
2018
|
|
503,929 (6)
|
|
—
|
|
|
—
|
|
|
—
|
|
289,945
|
|
105,968
|
|
899,842
|
Executive Vice President,
|
|
2017
|
|
446,443
|
|
—
|
|
|
—
|
|
|
602,250
|
|
447,525
|
|
79,563
|
|
1,575,781
|
Advanced Products
|
|
2016
|
|
398,923
|
|
—
|
|
|
—
|
|
|
—
|
|
427,763
|
|
214,286
|
|
1,040,972
|
(1)
|
For Mr. Kelley, the amounts listed in the Bonus column reflect the Service Bonus paid for the periods of January 1, 2018 through December 31, 2018 and February 27, 2017 through December 31, 2017. For Ms. Faust, the amount listed in the Bonus column reflects a discretionary bonus for performance in 2018 on key strategic corporate initiatives.
|
(2)
|
The amounts in the Stock Awards column reflect the aggregate grant date fair value of restricted stock awards granted during the year ended December 31, 2017, calculated in accordance with FASB ASC 718 and excluding the impact of estimated forfeitures related to service-based vesting conditions. Assumptions used in the calculation of these amounts are included in Note 4 to our Consolidated Financial Statements included in our Annual Report on Form 10-K filed with the SEC on February 22, 2019. These amounts reflect the accounting expense for these awards, and do not correspond to the actual value, if any, that will be recognized by the named executive officers.
|
(3)
|
The amounts in the Option Awards column reflect the aggregate grant date fair value of option awards for the years ended December 31, 2017 and 2016, calculated in accordance with FASB ASC 718 and excluding the impact of estimated forfeitures related to service-based vesting conditions. Assumptions used in the calculation of these amounts are included in Note 4 to our Consolidated Financial Statements included in our Annual Report on Form 10-K filed with the SEC on February 22, 2019. These amounts reflect the accounting expense for these awards, and do not correspond to the actual value, if any, that will be recognized by the named executive officers.
|
(4)
|
Represents amounts earned pursuant to the terms of the Executive Bonus Plan with respect to the years ended December 31, 2018, 2017 and 2016.
|
(5)
|
See the 2018 All Other Compensation Table below for additional information.
|
(6)
|
A portion of Mr. Rutten's salary was converted from Singapore dollars based on the average exchange rate for the period from June 1, 2018 through December 31, 2018, which was 1.37.
|
Name
|
|
|
|
Auto
Fringe
($)(1)
|
|
401(k)
Match
($)(2)
|
|
Executive
Medical
Exam
($)(3)
|
|
Relocation and Housing Payments
($)(4)
|
|
Tax Related Payments
($)(5)
|
|
Total ($)
|
||
Stephen D. Kelley
|
|
2018
|
|
—
|
|
10,000
|
|
5,091
|
|
—
|
|
—
|
|
15,091
|
|
|
|
|
2017
|
|
—
|
|
10,000
|
|
—
|
|
—
|
|
—
|
|
10,000
|
|
|
|
|
2016
|
|
—
|
|
10,000
|
|
2,270
|
|
—
|
|
—
|
|
12,270
|
|
|
Megan Faust
|
|
2018
|
|
—
|
|
10,000
|
|
1,077
|
|
—
|
|
—
|
|
11,077
|
|
|
|
|
2017
|
|
—
|
|
10,000
|
|
4,514
|
|
—
|
|
—
|
|
14,514
|
|
|
|
|
2016
|
|
—
|
|
10,000
|
|
4,109
|
|
—
|
|
—
|
|
14,109
|
|
|
Gil C. Tily
|
|
2018
|
|
—
|
|
10,000
|
|
1,071
|
|
—
|
|
—
|
|
11,071
|
|
|
|
|
2017
|
|
—
|
|
10,000
|
|
—
|
|
—
|
|
—
|
|
10,000
|
|
|
|
|
2016
|
|
—
|
|
10,000
|
|
4,692
|
|
—
|
|
—
|
|
14,692
|
|
|
John C. Stone
|
|
2018
|
|
—
|
|
10,000
|
|
2,452
|
|
—
|
|
—
|
|
12,452
|
|
|
|
|
2017
|
|
—
|
|
10,000
|
|
6,374
|
|
—
|
|
—
|
|
16,374
|
|
|
|
|
2016
|
|
—
|
|
10,000
|
|
—
|
|
—
|
|
—
|
|
10,000
|
|
|
Giel Rutten
|
|
2018
|
|
7,308 (6)
|
|
10,000
|
|
—
|
|
79,850 (6)
|
|
8,810
|
|
105,968
|
|
|
|
|
2017
|
|
—
|
|
10,000
|
|
9,113
|
|
6,053
|
|
54,397
|
|
79,563
|
|
|
|
|
2016
|
|
—
|
|
10,000
|
|
—
|
|
42,370
|
|
161,916
|
|
214,286
|
|
|
(1)
|
Represents the cost to us for automobile related items including lease payments, parking fees and insurance premiums.
|
(2)
|
Represents our matching contributions to the participants’ 401(k) accounts.
|
(3)
|
Represents the cost to us of a comprehensive annual physical examination made available to our executive officers.
|
(4)
|
Represents payments made to or on behalf of the named executive officer for relocation and housing expenses related to his company assignment.
|
(5)
|
Represents payments made to or on behalf of Mr. Rutten pursuant to our expatriate tax equalization program.
|
(6)
|
Converted from Singapore Dollar based on the average exchange rate for the period from June 1, 2018 through December 31, 2018, which was 1.37.
|
|
|
|
|
Estimated Future Payouts Under
Non-Equity Incentive Plan
Awards(1)
|
|
All Other Stock Awards: Numbers of Shares of Stock
(#)
|
|
All Other Option Awards: Numbers of Securities Underlying Options
(#)
|
|
Exercise or Base Price of Option Awards ($/Sh)
|
|
Grant Date Fair Value of
Stock
and
Option Awards
($)
|
||||
Name
|
|
Grant Date
|
|
Threshold
($)
|
|
Target
($)
|
|
Maximum
($)
|
|
|||||||
Stephen D. Kelley
|
|
2/7/2018
|
|
—
|
|
1,161,003
|
|
1,741,505
|
|
—
|
|
—
|
|
—
|
|
—
|
Megan Faust
|
|
2/7/2018
|
|
—
|
|
281,250
|
|
421,875
|
|
—
|
|
—
|
|
—
|
|
—
|
Gil C. Tily
|
|
2/7/2018
|
|
—
|
|
518,500
|
|
777,750
|
|
—
|
|
—
|
|
—
|
|
—
|
John C. Stone
|
|
2/7/2018
|
|
—
|
|
412,500
|
|
618,750
|
|
—
|
|
—
|
|
—
|
|
—
|
Giel Rutten
|
|
2/7/2018
|
|
—
|
|
365,630
|
|
548,445
|
|
—
|
|
—
|
|
—
|
|
—
|
(1)
|
Represents each named executive officer’s threshold, target and maximum bonus opportunity under the Executive Bonus Plan for 2018.
|
|
|
Option Awards
|
|
|
|
|
|
Stock Awards
|
||||
Name
|
|
Number of
Securities
Underlying
Unexercised
Options
Exercisable (#)
|
|
Number of
Securities
Underlying
Unexercised
Options
Unexercisable (#)
|
|
Option
Exercise
Price($)
|
|
Option
Expiration
Date
|
|
Number of Shares or Units of Stock That Have Not Vested (#)
|
|
Market Value of Shares or Units of Stock That Have Not Vested
($)(1)
|
Stephen D. Kelley
|
|
196,875
|
|
253,125 (2)
|
|
9.86
|
|
2/27/2027
|
|
—
|
|
—
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
112,500 (3)
|
|
738,000
|
Megan Faust
|
|
52,500
|
|
67,500 (4)
|
|
9.86
|
|
2/27/2027
|
|
—
|
|
—
|
|
|
42,187
|
|
32,813 (5)
|
|
8.88
|
|
9/12/2026
|
|
—
|
|
—
|
Gil C. Tily
|
|
76,562
|
|
98,438 (4)
|
|
9.86
|
|
2/27/2027
|
|
—
|
|
—
|
|
|
12,500
|
|
—
|
|
4.28
|
|
9/9/2023
|
|
—
|
|
—
|
John C. Stone
|
|
65,625
|
|
84,375 (4)
|
|
9.86
|
|
2/27/2027
|
|
—
|
|
—
|
|
|
25,000
|
|
—
|
|
4.28
|
|
9/9/2023
|
|
—
|
|
—
|
Giel Rutten
|
|
65,625
|
|
84,375 (4)
|
|
9.86
|
|
2/27/2027
|
|
—
|
|
—
|
|
|
25,000
|
|
—
|
|
5.18
|
|
2/13/2024
|
|
—
|
|
—
|
(1)
|
The market value of the unvested shares of restricted stock is based on the closing market price of our common stock on December 31, 2018.
|
(2)
|
This stock option was granted on February 27, 2017 and vests in equal quarterly installments at the rate of 6.25% per quarter over four years.
|
(3)
|
The restricted stock was granted on February 27, 2017 and vests in equal quarterly installments at the rate of 6.25% per quarter over four years.
|
(4)
|
This stock option was granted on February 27, 2017 and vests over four years as follows: 25% of the shares subject to the option vest on the first anniversary of the grant date and 1/16th of the shares subject to the option vest quarterly thereafter.
|
(5)
|
This stock option was granted on September 12, 2016 and vests over four years as follows: 25% of the shares subject to the option vest on the first anniversary of the grant date and 1/16th of the shares subject to the option vest quarterly thereafter.
|
|
|
|||
|
Number of Shares
Acquired on Vesting
(#)
|
|
Value Realized on Vesting
($)(1)
|
|
Stephen D. Kelley
|
|
50,000
|
|
434,625
|
Megan Faust
|
|
—
|
|
—
|
Gil C. Tily
|
|
—
|
|
—
|
John C. Stone
|
|
—
|
|
—
|
Giel Rutten
|
|
—
|
|
—
|
(1)
|
This column represents the product of the number of shares vesting, multiplied by the per share market value of our common stock on the applicable vesting date.
|
Treatment of Outstanding Stock Options and Restricted Stock upon Various Events
|
||||||||||||
Voluntary
Resignation
|
|
Normal
Retirement
(1)
|
|
Involuntary
Not for
Cause
|
|
For Cause
Termination
|
|
Change in
Control
|
|
Death
|
|
Disability
|
|
|
|
|
|
|
|
||||||
No additional vesting of Restricted Stock or Stock Options; up to 3 months to exercise vested Stock Options
|
|
No additional vesting of Restricted Stock or Stock Options; up to 24 months to exercise vested Stock Options
|
|
No additional vesting of Restricted Stock or Stock Options; up to 3 months to exercise vested Stock Options
|
|
No additional vesting of Restricted Stock or Stock Options; up to 3 months to exercise vested Stock Options
|
|
Accelerated vesting of Restricted Stock and Stock Options (if not assumed); up to 3 months to exercise vested Stock Options
|
|
Accelerated vesting of Restricted Stock and Stock Options; up to 24 months to exercise vested Stock Options
|
|
Accelerated vesting of Restricted Stock and Stock Options; up to 24 months to exercise vested Stock Options
|
(1)
|
Normal retirement is defined as termination of service on or after the date when the sum of (i) the executive’s age (rounded down to the nearest whole month), plus (ii) the number of years (rounded down to the nearest whole month) that the executive has provided services equals or is greater than seventy-five (75).
|
|
|
Value of Accelerated Vesting of Unvested Shares of Restricted Stock and Unvested Stock Options
|
||||||||||||
Name
|
|
Voluntary
Resignation ($)
|
|
Normal
Retirement
($)
|
|
Involuntary
Not for
Cause ($)
|
|
For Cause
Termination ($)
|
|
Change-in
Control ($)
|
|
Death ($)
|
|
Disability ($)
|
Stephen D. Kelley
|
|
—
|
|
—
|
|
—
|
|
—
|
|
738,000
|
|
738,000
|
|
738,000
|
Megan Faust
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
Gil C. Tily
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
John C. Stone
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
Giel Rutten
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
•
|
each person or entity who is known by us to beneficially own 5% or more of our outstanding common stock;
|
•
|
each of our directors; and
|
•
|
each named executive officer.
|
Name and Address†
|
|
Number of
Shares
(a)
|
|
Percentage
Ownership
(%)
|
||
James J. Kim Family Group(b)
|
|
142,033,912
|
|
|
59.2
|
|
915 Investments LP(c)
|
|
49,594,980
|
|
|
20.7
|
|
Sujochil(c)
|
|
19,484,809
|
|
|
8.1
|
|
Dimensional Fund Advisors LP(d)
Building One
6300 Bee Cave Road
Austin, TX 78746
|
|
17,422,753
|
|
|
7.3
|
|
Douglas A. Alexander(e)
|
|
10,342
|
|
|
*
|
|
Roger A. Carolin(f)
|
|
234,576
|
|
|
*
|
|
Winston J. Churchill(g)
|
|
56,000
|
|
|
*
|
|
Megan Faust(h)
|
|
114,094
|
|
|
*
|
|
Stephen D. Kelley(i)
|
|
538,325
|
|
|
*
|
|
James J. Kim(j)
|
|
69,210,700
|
|
|
28.9
|
|
John T. Kim(k)
|
|
75,615,251
|
|
|
31.5
|
|
Susan Y. Kim(l)
|
|
66,005,435
|
|
|
27.5
|
|
MaryFrances McCourt(m)
|
|
10,342
|
|
|
*
|
|
Robert R. Morse(n)
|
|
132,176
|
|
|
*
|
|
Giel Rutten(o)
|
|
100,000
|
|
|
*
|
|
John C. Stone(p)
|
|
131,722
|
|
|
*
|
|
Gil C. Tily(q)
|
|
166,339
|
|
|
*
|
|
David N. Watson(r)
|
|
102,176
|
|
|
*
|
|
All directors and executive officers(15 individuals)(s)
|
|
143,766,071
|
|
|
59.6
|
|
*
|
Represents less than 1%.
|
†
|
The address for each person or entity is c/o Amkor Technology, Inc., 2045 East Innovation Circle, Tempe, Arizona 85284
|
(a)
|
The number and percentage of shares beneficially owned is determined in accordance with Rule 13d-3 under the Exchange Act, as amended. The information is not necessarily indicative of beneficial ownership for any other purpose. Under this rule, beneficial ownership includes any share over which the individual or entity has voting power or investment power. In computing the number of shares beneficially owned by a person and the percentage ownership of that person, shares of our common stock subject to options held by that person that will become exercisable within 60 days of February 28, 2019 are deemed outstanding. Unless otherwise indicated, each person or entity has sole voting and investment power with respect to shares shown as beneficially owned.
|
(b)
|
As reported by James J. Kim and other reporting persons on a Schedule 13D/A filed with the SEC on November 9, 2018 (the "Kim Schedule 13D") and on Forms 5 filed with the SEC on February 14, 2019 (the "Forms 5"), Mr. James
|
(c)
|
As reported by the Kim Schedule 13D.
|
(d)
|
The Dimensional Fund Advisors LP reported in a Schedule 13G filed with the Commission on February 8, 2019 that it beneficially owns these shares as of December 31, 2018.
|
(e)
|
Includes 4,657 shares issuable upon the exercise of stock options exercisable by Mr. Alexander within 60 days of February 28, 2019.
|
(f)
|
Includes 160,000 shares issuable upon the exercise of stock options exercisable by Mr. Carolin within 60 days of February 28, 2019.
|
(g)
|
Includes 40,000 shares issuable upon the exercise of stock options exercisable by Mr. Churchill within 60 days of February 28, 2019.
|
(h)
|
Includes 106,875 shares issuable upon the exercise of stock options exercisable by Ms. Faust within 60 days of February 28, 2019.
|
(i)
|
Includes 225,000 shares issuable upon the exercise of stock options exercisable by Mr. Kelley within 60 days of February 28, 2019.
|
(j)
|
Includes 100,000 shares issuable upon the exercise of options exercisable within 60 days of February 28, 2019. As reported by the Kim Schedule 13D and the Forms 5, of the 54,816,203 shares owned by James J. Kim individually, 49,594,980 shares are held by 915 Investments, LP, a partnership in which Mr. Kim is the sole general partner and of the 14,394,497 shares held by Mr. Kim in his capacity as trustee of certain Kim Trusts, he has shared investment power as to all such shares and no voting power as to 2,000,000 shares. Said number does not include 23 shares owned by Agnes C. Kim, Mr. Kim’s spouse, of which Mrs. Kim has sole voting and investment power. Mr. James J. Kim disclaims beneficial ownership of such 23 shares and shares that are held in his capacity as trustee.
|
(k)
|
Includes 207,500 shares issuable upon exercise of stock options exercisable within 60 days of February 28, 2019. As reported by the Kim Schedule 13D and the Forms 5, of the 27,021,745 shares held by John T. Kim individually, 6,189,831 shares are held by Sujoda Investments, L.P., a limited partnership established for the benefit of members of the James J. Kim Family, with respect to which John T. Kim has shared voting and investment power and 19,484,809 shares are owned by Sujochil, LP, a partnership established for the benefit of members of the James J. Kim family, of which John T. Kim is a general partner and a limited partner and has shared voting and investment power. 48,593,506 shares are held by John T. Kim in his capacity as trustee of certain Kim Trusts, of which 24,441,078 are subject to shared voting power and 40,999,505 are subject to shared investment power and John has no voting power as to 11,988,875 shares. John T. Kim disclaims beneficial ownership of shares that are held in his capacity as trustee and
|
(l)
|
Includes 65,000 shares issuable upon exercise of stock options exercisable within 60 days of February 28, 2019, As reported by the Kim Schedule 13D and the Forms 5, of the 31,518,610 shares held directly by Susan Y. Kim, 6,189,831 shares are owned by Sujoda Investments, L.P., a limited partnership established for the benefit of members of the James J. Kim family, with respect to which Susan Y. Kim has shared voting and investment power and 19,484,809 shares are owned by Sujochil, LP, a partnership established for the benefit of members of the James J. Kim family, of which Susan Y. Kim is a general partner and a limited partner and has shared voting and investment power. 34,486,825 shares are held by Susan Y. Kim in her capacity as trustee of certain Kim Trusts, of which 23,105,965 shares are subject to shared voting power and 34,486,825 shares are subject to shared investment power and Susan Y. Kim has no voting power as to 7,178,017 shares. Susan Y. Kim disclaims beneficial ownership of shares that are held in her capacity as trustee and to all shares held by Sujoda Investments, L.P. and Sujochil, LP, other than the shares attributable to her proportional ownership of such entities.
|
(m)
|
Includes 4,657 shares issuable upon the exercise of stock options exercisable by Ms. McCourt within 60 days of February 28, 2019.
|
(n)
|
Includes 100,000 shares issuable upon the exercise of stock options exercisable by Mr. Morse within 60 days of February 28, 2019.
|
(o)
|
Includes 100,000 shares issuable upon the exercise of stock options exercisable by Mr. Rutten within 60 days of February 28, 2019.
|
(p)
|
Includes 100,000 shares issuable upon the exercise of stock options exercisable by Mr. Stone within 60 days of February 28, 2019.
|
(q)
|
Includes 100,000 shares issuable upon the exercise of stock options exercisable by Mr. Tily within 60 days of February 28, 2019.
|
(r)
|
Includes 80,000 shares issuable upon the exercise of stock options exercisable by Mr. Watson within 60 days of February 28, 2019.
|
(s)
|
Includes 1,529,626 shares issuable upon the exercise of stock options exercisable within 60 days of February 28, 2019.
|
|
|
Year Ended
December 31,
|
||||||
|
|
2018
|
|
2017
|
||||
|
|
(In thousands)
|
||||||
Audit fees
|
|
$
|
4,805
|
|
|
$
|
4,251
|
|
Audit-related fees(1)
|
|
-
|
|
|
84
|
|
||
Tax fees(2)
|
|
824
|
|
|
386
|
|
||
All other fees(3)
|
|
3
|
|
|
3
|
|
||
|
|
$
|
5,632
|
|
|
$
|
4,724
|
|
(1)
|
Audit-related fees consist of fees associated with evaluation of a new accounting standard in 2017.
|
(2)
|
Tax fees consist primarily of fees associated with tax compliance, advice and planning services.
|
(3)
|
All other fees includes a license fee for access to accounting and reporting research tools in both 2017 and 2018.
|
•
|
the professional qualifications of the lead audit partner and other key engagement partners relative to the current and ongoing needs of the company;
|
•
|
historical and recent performance on the company’s audits, including the extent and quality of communications with the Audit Committee related thereto;
|
•
|
the appropriateness of fees relative to both efficiency and audit quality;
|
•
|
independence policies and processes for maintaining its independence;
|
•
|
tenure as the company’s independent registered public accounting firm and its related depth of understanding of the company’s businesses, operations and systems and accounting policies and practices;
|
•
|
capability, expertise and efficiency in handling the breadth and complexity of the company’s operations across the globe;
|
•
|
demonstrated professional integrity and objectivity, which is furthered by the Audit Committee-led process to rotate and select the lead audit partner and other key engagement partners at least every five years or as otherwise required by applicable law or regulation, and which was done most recently in 2016 for the lead audit partner; and
|
•
|
the relative benefits, challenges, overall advisability and potential impact of selecting a different independent public accounting firm.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
No Customers Found
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|